Europe's Home for Peptide Therapeutics Innovation
The inaugural Peptide-Based Therapeutics Summit Europe is the dedicated meeting uniting Europe's peptide community to accelerate the discovery, development and commercialisation of next-generation peptide therapeutics. Join leading pharma, biotech and academic experts to explore the latest advances in AI-driven discovery, macrocyclic peptides, oral delivery, formulation, CMC and manufacturing. Through cutting-edge scientific presentations, interactive workshops and unrivalled networking opportunities, gain practical strategies, benchmark innovation and build the collaborations needed to bring breakthrough peptide medicines to patients faster.
What to Expect?
Advance the Next Generation of Peptide Discovery
Learn how leading organisations are leveraging AI, computational chemistry, macrocyclic peptide design and next-generation screening technologies to accelerate hit identification, optimise candidates and unlock previously undruggable targets.
Redefine Oral Peptide Therapeutics
Discover the latest innovations in oral bioavailability, formulation science and targeted delivery, exploring how industry leaders are moving beyond traditional permeation enhancers to create patient-friendly peptide medicines.
Bridge Discovery with Development
Gain practical strategies to optimise peptide stability, half-life, developability and translational success while overcoming CMC, manufacturing and regulatory challenges to accelerate programmes towards commercialisation.
Learn from Europe's Peptide Innovators
Hear directly from senior experts from the likes of AstraZeneca, Novo Nordisk, Johnson & Johnson, Boehringer Ingelheim, Zealand Pharma, and more as they share scientific breakthroughs, real-world case studies and lessons learned across discovery, chemistry, formulation, delivery and manufacturing.
Build High-Value Scientific Connections
Engage in interactive workshops, panel discussions, roundtables, poster sessions and dedicated networking opportunities to exchange ideas, forge new collaborations and strengthen your network across Europe's peptide therapeutics community.
Attending Companies Include